LGLL - Large Granular Lymphocytic Leukemia research hub

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

This study is testing a new medicine called DR-01 for people with certain types of blood cancers, specifically Large Granular Lymphocytic Leukemia (LGLL) and various cytotoxic lymphomas. It aims to see if DR-01 is safe, well-tolerated, and effective in shrinking these cancers.